muc1 dendritic cell vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2009 (NCT00852007)
Timeline
Indications
Mechanism of action
- Mucin-1Immunity, active
MUC1 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous dendritic cells expressing tn-muc1
- muc1 dendritic cell vaccine
- muc1 dendritic cell vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01617629 | Phase 2 | Dec 1, 2011 | Immutep S.A., Indiana University, Marin Cancer Care, Scripps, University of Queensland, University of Washington |
| NCT00852007 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2009 | Hamilton Health Sciences Corporation, McMaster University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hamilton Health Sciences Corporation | Academic/Hospital | 1 | 1 | 1 | 2009 |
| Immutep S.A. | For profit | 1 | 1 | 1 | 2011 |
| Indiana University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Marin Cancer Care | Academic/Hospital | 1 | 0 | 1 | 2011 |
| McMaster University | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Scripps | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of Queensland | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2011 |
8 organizations
Page 1 / 1